April 21, 2014 — Decision Resources Group announced in a report that Servier's ivabradine (procoralan) is set to become the clinical gold standard in the treatment of chronic heart failure (CHF). Already available in Europe, where it has enjoyed moderate use in CHF and stable angina patients, ivabradine's clinical profile could prime this agent for a potentially successful launch in the United States, where Amgen own the marketing rights to procoralan.
April 21, 2014 — Cardiologists and cancer experts at the Mount Sinai Hospital in Manhattan have joined forces to establish its first cardio-oncology clinic at the Tisch Cancer Institute.
Providence Saint Joseph Medical Center in Burbank, Calif., is the first hospital in the nation to conduct a magnetic resonance imaging (MRI) scan of a patient implanted with a new MRI-compatible pacemaker — a breakthrough because metal implants often exclude patients from this imaging because of the strong magnetic force.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Treatment options for high-risk heart patients with severely calcified coronary artery disease (CAD) have been limited for more than 20 years. Now, Robert Wood Johnson University Hospital (RWJUH) in New Brunswick, N.J., offers a new alternative to open up blocked arteries.
Tendyne Holdings Inc. has secured $25 million in an oversubscribed Series C financing led by Apple Tree Partners, along with Boulle Group members and other existing investors.
Cytori Therapeutics announced publication of safety and efficacy data from a 36 month European clinical trial of Cytori Cell Therapy in patients with chronic ischemic heart failure.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
April 18, 2014 — New research presented at the 34th annual meeting of the International Society for Heart and Lung Transplantation (ISHLT) demonstrated the CorMatrix particulate extracellular matrix (P-ECM) alone and as an adjunct to HeartWare International Inc.’s left ventricular assist device (LVAD) improved cardiac function in a bovine ischemic heart failure model, as compared to LVAD alone.
April 18, 2014 — A University of California, San Diego scientist has developed a new biomaterial that could potentially treat heart attacks. Karen Christman, Ph.D., associate professor of bioengineering at UC San Diego Jacobs School of Engineering, has been at work on a new injectable hydrogel, which is designed to repair damaged cardiac tissue following a heart attack.
April 18, 2014 — AliveCor announced the online publication of study results of the SEARCH-AF study. The SEARCH-AF study, conducted in Australia, screened 1,000 customers over 65 years old for atrial fibrillation (AF) in 10 community pharmacies in suburban Sydney.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Medtronic announced the U.S. Food and Drug Administration (FDA) approved an expanded indication for biventricular (BiV) pacing with Medtronic cardiac resynchronization therapy-pacemakers and -defibrillators (CRT-P and CRT-D). Medtronic CRT devices are now approved to treat patients with atrioventricular (AV) block and left ventricular (LV) systolic dysfunction, reducing heart failure hospitalizations and mortality, and improving cardiac function in these patients.
Toshiba America Medical Systems Inc. received approval to operate (ATO) with the U.S. Air Force, making Toshiba the only current manufacturer to have a fully certified computed tomography (CT) system for use on the Air Force Network.
Data presented from two meta-analyses using the Atherotech Vertical Auto Profile (VAP) lipid panel showed the impact high-density lipoprotein (HDL) cholesterol and remnant lipoprotein (RLP) cholesterol have on determining a patient’s risk for hard coronary heart disease (CHD) endpoints, such as myocardial infarction or coronary death.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Healthy postmenopausal women who drink two or more diet drinks a day may be more likely to have a heart attack, stroke or other cardiovascular problems, according to research to be presented at the American College of Cardiology’s 63rd Annual Scientific Session.
April 16, 2014 — Covidien announced it has notified customers of a voluntary recall to address an issue with certain lots of its Pipeline embolization device and Alligator retrieval device, where the polytetrafluoroethylene (PTFE) coating applied to the delivery wire could delaminate and detach from the devices.
April 16, 2014 — Abbott announced it has completed enrollment of three clinical trials to support approvals of the company's Absorb bioresorbable vascular scaffold (BVS) in the United States, Japan and China. Combined, the U.S., Japan and China account for more than 50 percent of the world's heart stent market. Absorb received CE mark in 2011 and is available in more than 60 countries around the world.